COVID-19 Research Paper Volume 13, Issue 20 pp 23442—23458

Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019


Figure 2. Associations between serum amylase and mortality, as well as secondary outcomes. (A) Restricted cubic splines analysis illustrated the association between serum amylase and all cause mortality. (B) Kaplan-Meier curves for cumulative probability of COVID-19 mortality during hospitalization in patients with different level of serum amylase. (C) Multivariable mixed-effect logistic regression model indicated that hyperamylasemia was independently associated with sepsis, DIC, Cardiac injury, ARDS and AKI.